['multiple sclerosis']
['placebo']

        Inclusion Criteria:

          -  Diagnosis of relapsed multiple sclerosis

          -  Active disease

          -  Greater than 1 relapse in prior 2 years

        Exclusion Criteria:

          -  Treatment with anti-CD20 monoclonal antibody within the last 12 months

          -  Treatment with alemtuzumab within the last 12 months

          -  Pregnant or nursing mothers
      